Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 4/20 | 0.56 |
| ▸ | GABRB2 | P47870 | 4/20 | 0.56 |
| ▸ | IAPP | P10997 | 4/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.38 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.38 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.36 |
| ▸ | RIPK1 | Q13546 | 2/20 | 0.35 |
| ▸ | DAO | P14920 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6404755 | 0.94 | GABRA1 (0.50) | GABRA1GABRB2IAPPCA2ALOX5 | |
| SCHEMBL25995155 | 0.87 | GABRA1 (0.52) | GABRA1GABRB2IAPPCA2ALOX5 | |
| SCHEMBL430927 | 0.86 | CA2 (0.57) | GABRA1GABRB2IAPPCA2ALOX5 | |
| SCHEMBL35793 | 0.85 | GABRA1 (0.50) | GABRA1GABRB2IAPPCA2ALOX5 | |
| SCHEMBL25995220 | 0.84 | GABRA1 (0.48) | GABRA1GABRB2IAPPALOX5PTGS2 | |
| SCHEMBL25995234 | 0.84 | GABRA1 (0.48) | GABRA1GABRB2IAPPALOX5PTGS2 | |
| SCHEMBL25995260 | 0.84 | GABRA1 (0.48) | GABRA1GABRB2IAPPALOX5PTGS2 | |
| SCHEMBL25995245 | 0.84 | GABRA1 (0.48) | GABRA1GABRB2IAPPALOX5PTGS2 | |
| SCHEMBL118255 | 0.80 | TAAR1 (0.54) | CA2ALDH1A1 | |
| SCHEMBL25998048 | 0.77 | GABRA1 (0.46) | GABRA1GABRB2IAPPALOX5PTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 94 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113698279-B | Method for separating and extracting 3, 5-xylenol from industrial xylenol | 盐城工学院 | 2022-08-23 | — | — | CN | claimed |
| CN-113698279-A | Method for separating and extracting 3, 5-xylenol from industrial xylenol | 盐城工学院 | 2021-11-26 | — | — | CN | claimed |
| CN-112159628-A | Preparation method of adhesive resin film for aluminum alloy composite curtain wall board | 安徽兆鑫铝业科技有限公司 | 2021-01-01 | — | — | CN | claimed |
| US-8585454-B2 | Display device, method of manufacturing the same, and manufacturing the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2013-11-19 | — | — | US | claimed |
| US-20120018679-A1 | DISPLAY DEVICE, METHOD OF MANUFACTURING THE SAME, AND COMPOSITION FOR USE IN MANUFACTURING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2012-01-26 | — | — | US | claimed |
| US-20070153371-A1 | DISPLAY DEVICE, METHOD OF MANUFACTURING THE SAME, AND COMPOSITION FOR USE IN MANUFACTURING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2007-07-05 | — | — | US | claimed |
| US-6197226-B1 | COMPRISING DIPPING RESIN INTO A LIQUID CONTAINING POLAR COMPOUND SELECTED FROM POLAR INORGANIC COMPOUNDS AND POLAR ORGANIC COMPOUNDS AND TINTING RESIN, WHEREIN RESIN IS OBTAINED BY CURING BY POLYMERIZATION A SULFUR CONTAINING COMPOUND | MITSUBISHI GAS CHEMICAL COMPANY (JP) | 2001-03-06 | — | — | US | claimed |
| US-20260008766-A1 | EPISULFIDE COMPOUND AND OPTICAL MATERIAL COMPOSITION THEREOF | Efirm New Material Co., Ltd. (CN) | 2026-01-08 | — | — | US | disclosed |
| US-12391897-B2 | Lubricating oil composition | IDEMITSU KOSAN CO., LTD. (JP) | 2025-08-19 | — | — | US | disclosed |
| WO-2024252940-A1 | COMPOUND AND COMPOSITION CONTAINING SAME | 住友化学株式会社 | 2024-12-12 | — | — | WO | disclosed |
| WO-2024170002-A1 | NOVEL EPISULFIDE COMPOUND AND OPTICAL MATERIAL COMPOSITION THEREOF | 益丰新材料股份有限公司 | 2024-08-22 | — | — | WO | disclosed |
| WO-2024171777-A1 | COMPOUND AND METHOD FOR PRODUCING SAME, COMPOSITION, CURED PRODUCT, DISPLAY DEVICE, AND SOLID-STATE IMAGE SENSOR | 住友化学株式会社 | 2024-08-22 | — | — | WO | disclosed |
| CN-112424193-B | Episulfide compound and composition for optical material | 三菱瓦斯化学株式会社 | 2024-03-26 | — | — | CN | disclosed |
| EP-0980696-A1 | Process for treating a compound having epithio structures for disposal | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2000-02-23 | — | — | EP | disclosed |
| EP-0928802-A2 | Process for tinting a resin having a large refractivity index and optical material tinted by the process | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 1999-07-14 | — | — | EP | disclosed |
| EP-0817813-A1 | POLYOLEFIN COMPOSITION SUITED FOR METAL COATING BY FLAME SPRAYING | Montell North America Inc. (US) | 1998-01-14 | — | — | EP | disclosed |
| EP-0793688-A1 | POLYMER COMPOSITIONS CONTAINING AMINE OXIDE STABILIZER COMPOSITIONS | GENERAL ELECTRIC COMPANY (US) | 1997-09-10 | — | — | EP | disclosed |
| WO-1997028213-A1 | POLYOLEFIN COMPOSITION SUITED FOR METAL COATING BY FLAME SPRAYING | MONTELL NORTH AMERICA INC. (IT) | 1997-08-07 | — | — | WO | disclosed |
| WO-1997011993-A1 | POLYMER COMPOSITIONS CONTAINING AMINE OXIDE STABILIZER COMPOSITIONS | GENERAL ELECTRIC COMPANY (US) | 1997-04-03 | — | — | WO | disclosed |
| US-4032547-A | OXIDATION OF HINDERED PHENOLS, FERRICYANIDE AND PERSULFATE OXIDIZERS | GULF RESEARCH & DEVELOPMENT COMPANY (US) | 1977-06-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260008766-A1 | EPISULFIDE COMPOUND AND OPTICAL MATERIAL COMPOSITION THEREOF | LATS1, LATS2, TST | GABRA1 2005/4885GABRB2 1268/4885IAPP 2633/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.